INS and obesity due to melanocortin 4 receptor deficiency: Although adipose tissue is a central metabolic organ involved in the pathogenesis of obesity-related metabolic diseases, the potential health benefits of HTGT and EMIQ treatment, such as insulin sensitivity and anti-inflammatory effects in other metabolic organs, need further investigation.